Viking Therapeutics, Inc. (VKTX)
33.23
-0.66
(-1.95%)
USD |
NASDAQ |
Aug 24, 16:00
33.55
+0.32
(+0.96%)
After-Hours: 04:41
Viking Therapeutics Market Cap : 3.876B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.876B |
| August 21, 2026 | 3.953B |
| August 20, 2026 | 4.008B |
| August 19, 2026 | 4.197B |
| August 18, 2026 | 3.893B |
| August 17, 2026 | 3.923B |
| August 14, 2026 | 3.872B |
| August 13, 2026 | 3.843B |
| August 12, 2026 | 3.969B |
| August 11, 2026 | 3.943B |
| August 10, 2026 | 4.018B |
| August 07, 2026 | 3.997B |
| August 06, 2026 | 3.885B |
| August 05, 2026 | 3.909B |
| August 04, 2026 | 3.843B |
| August 03, 2026 | 3.804B |
| July 31, 2026 | 3.703B |
| July 30, 2026 | 3.862B |
| July 29, 2026 | 3.900B |
| July 28, 2026 | 3.950B |
| July 27, 2026 | 4.068B |
| July 24, 2026 | 4.032B |
| July 23, 2026 | 4.101B |
| July 22, 2026 | 4.324B |
| July 21, 2026 | 4.398B |
| Date | Value |
|---|---|
| July 20, 2026 | 4.216B |
| July 17, 2026 | 4.297B |
| July 16, 2026 | 4.215B |
| July 15, 2026 | 4.382B |
| July 14, 2026 | 4.400B |
| July 13, 2026 | 4.418B |
| July 10, 2026 | 4.504B |
| July 09, 2026 | 4.768B |
| July 08, 2026 | 4.631B |
| July 07, 2026 | 4.883B |
| July 06, 2026 | 4.486B |
| July 02, 2026 | 4.339B |
| July 01, 2026 | 4.344B |
| June 30, 2026 | 4.521B |
| June 29, 2026 | 4.582B |
| June 26, 2026 | 4.409B |
| June 25, 2026 | 4.287B |
| June 24, 2026 | 4.389B |
| June 23, 2026 | 4.034B |
| June 22, 2026 | 3.751B |
| June 18, 2026 | 3.521B |
| June 17, 2026 | 3.510B |
| June 16, 2026 | 3.436B |
| June 15, 2026 | 3.434B |
| June 12, 2026 | 3.332B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 138.73B |
| Eli Lilly & Co. | 1.174T |
| Regeneron Pharmaceuticals, Inc. | 85.67B |
| Skye Bioscience, Inc. | 76.26M |
| Eledon Pharmaceuticals, Inc. | 275.84M |
Market Cap Related Metrics
| PEG Ratio | -0.035 |
| Price to Book Value | 9.494 |
| Price | 33.23 |
| Earnings Yield | -14.03% |
| PEGY Ratio | -0.035 |